Related references
Note: Only part of the references are listed.Polycystin 2 regulates mitochondrial Ca2+ signaling, bioenergetics, and dynamics through mitofusin 2
Ivana Y. Kuo et al.
SCIENCE SIGNALING (2019)
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial
Norberto Perico et al.
PLOS MEDICINE (2019)
Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study
Laura Girardat-Rotar et al.
JOURNAL OF NEPHROLOGY (2018)
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial
Vicente E. Torres et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease
Stephen L. Seliger et al.
AMERICAN JOURNAL OF NEPHROLOGY (2018)
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
Marie E. Edwards et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Cilia-localized LKB1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney
Amandine Viau et al.
EMBO JOURNAL (2018)
Molecular Actions of PPARα in Lipid Metabolism and Inflammation
Nadia Bougarne et al.
ENDOCRINE REVIEWS (2018)
Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease
Irfana Soomro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Lkb1 deficiency confers glutamine dependency in polycystic kidney disease
Ebony M. Flowers et al.
NATURE COMMUNICATIONS (2018)
A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed
Cheng-Chao Lin et al.
SCIENTIFIC REPORTS (2018)
Polycystin-2 is an essential ion channel subunit in the primary cilium of the renal collecting duct epithelium
Xiaowen Liu et al.
ELIFE (2018)
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D. Courtney et al.
CELL METABOLISM (2018)
Mitochondrial fidelity and metabolic agility control immune cell fate and function
Michael N. Sack
JOURNAL OF CLINICAL INVESTIGATION (2018)
Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease
Marcelo F. Cassini et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Metabolism and mitochondria in polycystic kidney disease research and therapy
Valeria Padovano et al.
NATURE REVIEWS NEPHROLOGY (2018)
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease The DIPAK 1 Randomized Clinical Trial
Esther Meijer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways
Christine Podrini et al.
COMMUNICATIONS BIOLOGY (2018)
PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice
Ronak Lakhia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
The role of fatty acid β-oxidation in lymphangiogenesis
Brian W. Wong et al.
NATURE (2017)
Ciliopathies
Daniela A. Braun et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Genome-wide association study identifies novel susceptible loci and highlights Wnt/beta-catenin pathway in the development of adolescent idiopathic scoliosis
Zezhang Zhu et al.
HUMAN MOLECULAR GENETICS (2017)
Sexual Dimorphic Pattern of Renal Transporters and Electrolyte Homeostasis
Luciana C. Veiras et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
Yu Ishimoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function
Valeria Padovano et al.
MOLECULAR BIOLOGY OF THE CELL (2017)
New treatment paradigms for ADPKD: moving towards precision medicine
Matthew B. Lanktree et al.
NATURE REVIEWS NEPHROLOGY (2017)
Nutritional Management of Chronic Kidney Disease
Kamyar Kalantar-Zadeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Microtubules acquire resistance from mechanical breakage through intralumenal acetylation
Zhenjie Xu et al.
SCIENCE (2017)
Ciliary Mechanisms of Cyst Formation in Polycystic Kidney Disease
Ming Ma et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
Sachin Hajarnis et al.
NATURE COMMUNICATIONS (2017)
PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP/PKA signalling
Stefania Monterisi et al.
ELIFE (2017)
Targeting Metabolism for Cancer Therapy
Alba Luengo et al.
CELL CHEMICAL BIOLOGY (2017)
A Guide for the Design of Pre-clinical Studies on Sex Differences in Metabolism
Franck Mauvais-Jarvis et al.
CELL METABOLISM (2017)
Mitochondrial DNA in innate immune responses and inflammatory pathology
A. Phillip West et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies
Hong Ye et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
2-Deoxy-D-Glucose Ameliorates PKD Progression
Marco Chiaravalli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Food Restriction Ameliorates the Development of Polycystic Kidney Disease
Gina Warner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease
Debbie Zittema et al.
AMERICAN JOURNAL OF NEPHROLOGY (2016)
Studying both sexes: a guiding principle for biomedicine
Janine Austin Clayton
FASEB JOURNAL (2016)
PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection
Mei T. Tran et al.
NATURE (2016)
Roles of mTOR complexes in the kidney: implications for renal disease and transplantation
Daniel Fantus et al.
NATURE REVIEWS NEPHROLOGY (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex
Monika Pema et al.
NATURE COMMUNICATIONS (2016)
A protein interaction map for cell-cell adhesion regulators identifies DUSP23 as a novel phosphatase for β-catenin
Lisa Leon Gallegos et al.
SCIENTIFIC REPORTS (2016)
The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism
Said Izreig et al.
CELL REPORTS (2016)
Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults The CALERIE 2 Randomized Clinical Trial
Corby K. Martin et al.
JAMA INTERNAL MEDICINE (2016)
Tuberous sclerosis complex
Elizabeth P. Henske et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease
Luis F. Menezes et al.
EBIOMEDICINE (2016)
A novel effect of DMOG on cell metabolism: direct inhibition of mitochondrial function precedes HIF target gene expression
Alexander V. Zhdanov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2015)
Metabolic Regulation and Energy Homeostasis through the Primary Cilium
Edwin C. Oh et al.
CELL METABOLISM (2015)
mTOR signaling in cellular and organismal energetics
Verena Albert et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Pyruvate Dehydrogenase Kinase 1 Participates in Macrophage Polarization via Regulating Glucose Metabolism
Zheng Tan et al.
JOURNAL OF IMMUNOLOGY (2015)
Decreasing incidence of renal replacement therapy over time at the critical 50-59-year age range suggests a role for nephroprotective therapy in ADPKD
Laura Rodriguez-Osorio et al.
KIDNEY INTERNATIONAL (2015)
Fatty acid carbon is essential for dNTP synthesis in endothelial cells
Sandra Schoors et al.
NATURE (2015)
Vasopressin and disruption of calcium signalling in polycystic kidney disease
Fouad T. Chebib et al.
NATURE REVIEWS NEPHROLOGY (2015)
The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease
Tamina Seeger-Nukpezah et al.
NATURE REVIEWS NEPHROLOGY (2015)
Investigational cancer drugs targeting cell metabolism in clinical development
Douglas W. Sborov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Tolvaptan plus Pasireotide Shows Enhanced Efficacy in a PKD1 Model
Katharina Hopp et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
Hyun Mi Kang et al.
NATURE MEDICINE (2015)
Effects of hydration in rats and mice with polycystic kidney disease
Katharina Hopp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
The Atypical Cadherin Fat Directly Regulates Mitochondrial Function and Metabolic State
Anson Sing et al.
CELL (2014)
Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation
Joyce V. Lee et al.
CELL METABOLISM (2014)
FGF21 is an endocrine signal of protein restriction
Thomas Laeger et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Adenylyl Cyclase 6 Deficiency Ameliorates Polycystic Kidney Disease
Sara Rees et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
VDAC phosphorylation, a lipid sensor influencing the cell fate
Cecile Martel et al.
MITOCHONDRION (2014)
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease
Edwin M. Spithoven et al.
KIDNEY INTERNATIONAL (2014)
Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
Ji Zhang et al.
MOLECULAR CELL (2014)
Metabolism of stromal and immune cells in health and disease
Bart Ghesquiere et al.
NATURE (2014)
Mitochondrial form and function
Jonathan R. Friedman et al.
NATURE (2014)
NIH to balance sex in cell and animal studies
Janine A. Clayton et al.
NATURE (2014)
Effects of dietary interventions on incidence and progression of CKD
Nishank Jain et al.
NATURE REVIEWS NEPHROLOGY (2014)
Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
Eiji Higashihara et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
Robert W. Schrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sex-Dependent Gene Expression in Human Pluripotent Stem Cells
Daniel Ronen et al.
CELL REPORTS (2014)
Polycystin Signaling Is Required for Directed Endothelial Cell Migration and Lymphatic Development
Patricia Outeda et al.
CELL REPORTS (2014)
Molecular Links between Caloric Restriction and Sir2/SIRT1 Activation
Yu Wang
DIABETES & METABOLISM JOURNAL (2014)
Gender and the Prevalence and Progression of Renal Disease
Joel Neugarten et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2013)
Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury
Andrea Soljancic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
VDAC3 and Mps1 negatively regulate ciliogenesis
Shubhra Majumder et al.
CELL CYCLE (2013)
mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation
Masahiro Morita et al.
CELL METABOLISM (2013)
Sex differences in ischemia/reperfusion-induced acute kidney injury are dependent on the renal sympathetic nervous system
Ryosuke Tanaka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Pasireotide Is More Effective than Octreotide in Reducing Hepatorenal Cystogenesis in Rodents with Polycystic Kidney and Liver Diseases
Tatyana V. Masyuk et al.
HEPATOLOGY (2013)
Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease
Xia Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Macrophages promote polycystic kidney disease progression
Katherine I. Swenson-Fields et al.
KIDNEY INTERNATIONAL (2013)
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
Anna Caroli et al.
LANCET (2013)
CELL BIOLOGY Molecular clearance at the cell's antenna
Valentina Cianfanelli et al.
NATURE (2013)
Functional interaction between autophagy and ciliogenesis
Olatz Pampliega et al.
NATURE (2013)
Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites
Zaiming Tang et al.
NATURE (2013)
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3
Sylvia Hoff et al.
NATURE GENETICS (2013)
Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease
Ming Ma et al.
NATURE GENETICS (2013)
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
Isaline Rowe et al.
NATURE MEDICINE (2013)
TNF-α blockade is ineffective in animal models of established polycystic kidney disease
Jeffrey Roix et al.
BMC NEPHROLOGY (2013)
Caffeine intake by patients with autosomal dominant polycystic kidney disease
L. C. Vendramini et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2012)
Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study
Julie A. Mattison et al.
NATURE (2012)
A unifying model for mTORC1-mediated regulation of mRNA translation
Carson C. Thoreen et al.
NATURE (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh et al.
NATURE (2012)
The cellular and signaling networks linking the immune system and metabolism in disease
Olivia Osborn et al.
NATURE MEDICINE (2012)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Distinct perturbation of the translatome by the antidiabetic drug metformin
Ola Larsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Cyclic AMP Pathway
Paolo Sassone-Corsi
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Network Analysis of a Pkd1-Mouse Model of Autosomal Dominant Polycystic Kidney Disease Identifies HNF4α as a Disease Modifier
Luis F. Menezes et al.
PLOS GENETICS (2012)
Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells
Cibele S. Pinto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Warburg Revisited: Regulation of Mitochondrial Metabolism by Voltage-Dependent Anion Channels in Cancer Cells
Eduardo N. Maldonado et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
2-Hydroxyestradiol slows progression of experimental polycystic kidney disease
Sharon Anderson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Mitochondrial elongation during autophagy A stereotypical response to survive in difficult times
Ligia C. Gomes et al.
AUTOPHAGY (2011)
Cyclic AMP-mediated cyst expansion
Darren P. Wallace
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
Julie Adam et al.
CANCER CELL (2011)
Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease
Esther Meijer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Macrophages Promote Cyst Growth in Polycystic Kidney Disease
Anil Karihaloo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Distinct Macrophage Phenotypes Contribute to Kidney Injury and Repair
Sik Lee et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
During autophagy mitochondria elongate, are spared from degradation and sustain cell viability
Ligia C. Gomes et al.
NATURE CELL BIOLOGY (2011)
A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation
Sorin V. Fedeles et al.
NATURE GENETICS (2011)
Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug
E. Meijer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
Vinita Takiar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD)
Franck Belibi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresis
Jun Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?
G. Canaud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway
Melanie Metrich et al.
CELLULAR SIGNALLING (2010)
Individuals with mutations in XPNPEP3, which encodes a mitochondrial protein, develop a nephronophthisis-like nephropathy
John F. O'Toole et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Rapamycin Ameliorates PKD Resulting from Conditional Inactivation of Pkd1
Jonathan M. Shillingford et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
Primary cilia regulate mTORC1 activity and cell size through Lkb1
Christopher Boehlke et al.
NATURE CELL BIOLOGY (2010)
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pkd1 and Pkd2 Are Required for Normal Placental Development
Miguel A. Garcia-Gonzalez et al.
PLOS ONE (2010)
The cAMP Effectors Epac and Protein Kinase A (PKA) Are Involved in the Hepatic Cystogenesis of an Animal Model of Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Jesus M. Banales et al.
HEPATOLOGY (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Ricki J. Colman et al.
SCIENCE (2009)
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
Kathryn E. Wellen et al.
SCIENCE (2009)
Variation in age at ESRD in autosomal dominant polycystic kidney disease
Berenice Y. Reed et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Vasopressin directly regulates cyst growth in polycystic kidney disease
Xiaofang Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Sex-specific genetic architecture of human disease
Carole Ober et al.
NATURE REVIEWS GENETICS (2008)
A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1
Klaus Piontek et al.
NATURE MEDICINE (2007)
Disruption of intraflagellar in adult mice leads to transport obesity and slow-onset cystic kidney disease
James R. Davenport et al.
CURRENT BIOLOGY (2007)
Claims of sex differences - An empirical assessment in genetic associations
Nikolaos A. Patsopoulos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Autosomal dominant polycystic kidney disease
Vicente E. Torres et al.
LANCET (2007)
Development of polycystic kidney disease in juvenile cystic kidney mice: Insights into pathogenesis, ciliary abnormalities, and common features with human disease
Laurie A. Smith et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Increased water intake decreases progression of polycystic kidney disease in the PCK rat
Shizuko Nagao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease
JM Shillingford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors
E Allen et al.
HUMAN MOLECULAR GENETICS (2006)
Gender hormones and the progression of experimental polycystic kidney disease
KD Stringer et al.
KIDNEY INTERNATIONAL (2005)
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease
P Ruggenenti et al.
KIDNEY INTERNATIONAL (2005)
Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease
S Nagao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Fluid, electrolyte, and renal indices of hydration during 11 days of controlled caffeine consumption
LE Armstrong et al.
INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM (2005)
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease
VE Torres et al.
NATURE MEDICINE (2004)
Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury
KM Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition
M Ljubojevic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Regulation and organization of adenylyl cyclases and cAMP
DMF Cooper
BIOCHEMICAL JOURNAL (2003)
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist
VH Gattone et al.
NATURE MEDICINE (2003)
Kinetic properties of soluble adenylyl cyclase - Synergism between calcium and bicarbonate
TN Litvin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease
R Magistroni et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells
KR Hallows et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease
FA Belibi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4α and cAMP-response element-binding protein (CREB)
JF Louet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia
BK Yoder et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Sexual dimorphism in renal ischemia-reperfusion injury in rats:: Possible role of endothelin
V Müller et al.
KIDNEY INTERNATIONAL (2002)
Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease
GA Tanner et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Bending the MDCK cell primary cilium increases intracellular calcium
HA Praetorius et al.
JOURNAL OF MEMBRANE BIOLOGY (2001)
The pck rat: A new model that resembles human autosomal dominant polycystic kidney and liver disease
DJ Lager et al.
KIDNEY INTERNATIONAL (2001)
Dietary soy protein effects on disease and IGF-I in male and female Han : SPRD-cy rats
HM Aukema et al.
KIDNEY INTERNATIONAL (2001)
High dietary fat intake increases renal cyst disease progression in Han : SPRD-cy rats
S Jayapalan et al.
JOURNAL OF NUTRITION (2000)
Modification of polycystic kidney disease and fatty acid status by soy protein diet
MR Ogborn et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
